CXCR3 and neoplasm: In this study, flow cytometry analysis indicated that a single treatment cycle (three days post-treatment) did not yet have a detectable effect on activation and thus CXCR3 expression on tumor-infiltrating T cells but was only observed after 2 cycles of checkpoint inhibition five days post-treatment.